Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT) Meeting Abstract


Authors: Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; Dahi, P. B.; Koehne, G.; Tamari, R.; Carlow, D.; Giralt, S. A.; Landau, H.
Abstract Title: Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419405078
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.2023.2023
Notes: Meeting Abstract: 2023 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1053 Giralt
  2. Guenther Koehne
    194 Koehne
  3. Heather Jolie Landau
    419 Landau
  4. David Chung
    240 Chung
  5. Elizabeth Hoover
    29 Hoover
  6. Sean McCarthy Devlin
    601 Devlin
  7. Valkal Bhatt
    61 Bhatt
  8. Parastoo Bahrami Dahi
    295 Dahi
  9. Roni Tamari
    210 Tamari
  10. Gunjan Lalitchandra Shah
    419 Shah
  11. Dean Christian Carlow
    42 Carlow
  12. Andrew Pei-En Lin
    48 Lin
  13. Elaina Vitale Preston
    12 Preston